Pozen
Inc. (Nasdaq: POZN) will acquire Tribute Pharmaceuticals in a deal valued at
approximately $146 million. After completing the acquisition, Pozen
will relocate its headquarters to Ireland. The stock price climbed $1.43 to close at $8.98.
Pozen to acquire Tribute Pharmaceuticals
June 08, 2015 at 12:37 PM EDT
